Zongmin Zhao

Viral vector-based gene therapies in the clinic: An update.

Polyplex of peptide-mannan and RNA for intranasal delivery of TGF-β siRNA in treatment of pulmonary fibrosis

Integrating antigen capturing nanoparticles and type 1 conventional dendritic cell therapy for in situ cancer immunization

Stem cell therapies in the clinic

Integrating antigen capturing nanoparticles and type 1 conventional dendritic cell therapy for in situ cancer immunization.

Nanoparticle-boosted myeloid-derived suppressor cell therapy for immune reprogramming in multiple sclerosis

Cell therapies against brain tumors: Clinical development and emerging prospects

Stem cell therapies in the clinic.

Adoptive T‐cell therapies in the clinic

Adoptive T‐cell therapies in the clinic

Nanoparticle-boosted myeloid-derived suppressor cell therapy for immune reprogramming in multiple sclerosis.

PEGylated therapeutics in the clinic.

Hydrogels in the clinic: An update

Hydrogels in the clinic: An update.

In situ cellular hitchhiking of nanoparticles for drug delivery

Vaccine adjuvants for infectious disease in the clinic

Cancer vaccines in the clinic.

Vaccine adjuvants for infectious disease in the clinic.

Antibody drug conjugates in the clinic

Phalloidin-PAINT: Enhanced quantitative nanoscale imaging of F-actin

Antibody drug conjugates in the clinic.

Genetically engineered cell-derived nanovesicles for cancer immunotherapy

Hemostats in the clinic

Genetically engineered cell-derived nanovesicles for cancer immunotherapy.

Hemostats in the clinic.

Quantitative Superresolution Imaging of F-Actin in the Cell Body and Cytoskeletal Protrusions Using Phalloidin-Based Single-Molecule Labeling and Localization Microscopy

<scp>PEGylated</scp> therapeutics in the clinic

Alzheimer's and Parkinson's disease therapies in the clinic.

Cancer vaccines in the clinic

Systemic Tumor Suppression via Macrophage‐Driven Automated Homing of Metal‐Phenolic‐Gated Nanosponges for Metastatic Melanoma